Associations Between Physical Pain, Pain Management, and Frequency of Nonmedical Prescription Opioid Use Among Young Adults: A Sex-specific Analysis

Journal of Addiction Medicine
Tristan I EvansBrandon D L Marshall

Abstract

We sought to determine sex-specific associations between experiences of physical pain, pain management, and frequency of nonmedical prescription opioid (NMPO) use among young adults. Among participants enrolled in the Rhode Island Young Adult Prescription Drug Study, we identified associations between physical pain in the past 6 months, pain history, pain management, polysubstance use, and weekly NMPO use. In sex-specific models, independent correlates of weekly NMPO use were identified via modified stepwise Poisson regression. Of 199 participants, the mean age was 24.6, and 65.3% were male. The racial composition was 16.6% black, 60.8% white, and 22.1% mixed or other race. A total of 119 (59.8%) participants reported weekly or greater NMPO use. The majority of male (86.2%) and female (84.1%) participants reported ever experiencing severe pain. A majority of males (72.3%) and females (81.2%) reported that they engaged in NMPO use to treat their physical pain, and one-quarter (26.9%) of males and one-third (36.2%) of females had been denied a prescription from a doctor to treat severe pain. Among males, frequent NMPO use was independently associated with white race (P < 0.001) and reporting greater physical pain (P = 0.002). Amo...Continue Reading

References

Feb 25, 2000·Journal of Pain and Symptom Management·R N JamisonN P Katz
May 15, 2003·JAMA : the Journal of the American Medical Association·Andrew RosenblumRussell K Portenoy
Mar 23, 2004·American Journal of Epidemiology·Guangyong Zou
Mar 25, 2004·Annals of Emergency Medicine·Timothy Rupp, Kathleen A Delaney
Jan 19, 2006·Annals of Internal Medicine·Daniel P AlfordJeffrey H Samet
Nov 23, 2006·Drug and Alcohol Dependence·Jennifer AhernSandro Galea
Jan 8, 2008·Journal of the American Board of Family Medicine : JABFM·James E Lessenger, Steven D Feinberg
May 24, 2008·Addiction Science & Clinical Practice·Seddon R SavageSteven D Passik
Oct 8, 2008·Experimental and Clinical Psychopharmacology·Andrew RosenblumRussell K Portenoy
May 7, 2009·Journal of General Internal Medicine·Erin E KrebsKurt Kroenke
Jul 16, 2010·The Journal of Pain : Official Journal of the American Pain Society·Declan T BarryDavid A Fiellin
Sep 16, 2010·The Clinical Journal of Pain·Stephen F ButlerRobert N Jamison
Aug 14, 2012·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Meghan FibbiStephen E Lankenau
Sep 15, 2012·Drug and Alcohol Dependence·Karol SilvaStephen E Lankenau
May 28, 2013·Journal of Opioid Management·Ted Jones, Todd Moore
Jun 26, 2013·British Journal of Anaesthesia·E J Bartley, R B Fillingim
Sep 21, 2013·Drug and Alcohol Dependence·Traci C GreenPatricia Case
Dec 3, 2013·Substance Abuse Treatment, Prevention, and Policy·Pauline Voon, Thomas Kerr
Dec 19, 2014·Drug and Alcohol Review·Pauline VoonThomas Kerr
Jan 7, 2015·Pain Research & Management : the Journal of the Canadian Pain Society = Journal De La Société Canadienne Pour Le Traitement De La Douleur·Lianping TiThomas Kerr
Jun 24, 2015·The Journal of Pain : Official Journal of the American Pain Society·Pauline VoonThomas Kerr
Mar 15, 2016·Cleveland Clinic Journal of Medicine·Daniel G TobinWilliam C Becker
Mar 16, 2016·JAMA : the Journal of the American Medical Association·Deborah DowellRoger Chou
Dec 30, 2016·MMWR. Morbidity and Mortality Weekly Report·Rose A RuddLawrence Scholl

❮ Previous
Next ❯

Citations

Sep 23, 2020·JBJS Reviews·Jonathan D HaskelKirk A Campbell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.